DNAY
CODEX DNA INC (DNAY)
$1.381.47%▲
Market is closedMarket is closed – opens on 8 PM, 05 Dec 2022
– opens on 8 PM, 05 Dec 2022
Key Stats
$1.3501
Day's Range
$1.39
$1.35
52-Week Range
$11.32
| Returns | |
| 1 month return | 9.8% |
| 3 month return | 21.59% |
| 1 year return | 78.47% |
| 5 year return | 92.04% |
Company Information
Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.
| Organization | CODEX DNA INC |
| Employees | 212 |
| CEO | Dr. Todd R. Nelson MBA, Ph.D. |
| Industry | Healthcare |
Analyst Recommendation
based on 3 analysts ratings
Buy
100%
Buy
0%
Hold
0%
Sell
Based on 3 Wall street analysts offering stock ratings for CODEX DNA INC(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 371.01%Current
$1.38
Target
$6.5
Recommendation Trend
Based on 3 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 3 | 8 | 8 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Highlights
| Market Capitalization | 40.1M |
| Book Value | $1.81 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -1.84 |
| Wall Street Target Price | 6.5 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 0.79 |
| Enterprise Value | 13.5M |
| Enterprise Value/Revenue | 0.64 |
| Enterprise Value/Ebitda | -0.28 |
Technicals
| 50 Day MA | 1.68 |
| 200 Day MA | 3.52 |
Institutional Holdings
Northpond Ventures, LLC
33.35%
Franklin Resources Inc
8.06%
Millennium Management LLC
1.47%
Vanguard Group Inc
1.39%
Penbrook Management LLC
0.91%
RTW INVESTMENTS, LLC
0.34%
Discover more
Frequently Asked Questions
What is CODEX DNA INC share price today?
Can Indians buy CODEX DNA INC shares?
How can I buy CODEX DNA INC shares from India?
Can Fractional shares of CODEX DNA INC be purchased?
What are the documents required to start investing in CODEX DNA INC stocks?
What are today’s High and Low prices of CODEX DNA INC?
What are today’s traded volumes of CODEX DNA INC?
What is today’s market capitalisation of CODEX DNA INC?
What is the 52 Week High and Low Range of CODEX DNA INC?
How much percentage CODEX DNA INC is down from its 52 Week High?
How much percentage CODEX DNA INC is up from its 52 Week low?
What are the historical returns of CODEX DNA INC?
Who is the Chief Executive Officer (CEO) of CODEX DNA INC?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*